Jacopo Weindelmayer

Jacopo Weindelmayer

Auto-generated profile, based on publicly available information

Jacopo Weindelmayer

University of Verona

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2012 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
AZAndrea Zanoni
Andrea Zanoni
GVGiuseppe Verlato
Giuseppe Verlato
SGSimone Giacopuzzi
Simone Giacopuzzi
JWJ. Weindelmayer
J. Weindelmayer
FCF. Casella
F. Casella
GMGiovanni De Manzoni
Giovanni De Manzoni

1 August 2020 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
JWJacopo Weindelmayer
Jacopo Weindelmayer
VMValentina Mengardo
Valentina Mengardo
Alessandro VeltriAlessandro Veltri
Alessandro Veltri
Lorena TorroniLorena Torroni
Lorena Torroni
EZEnhao Zhao
Enhao Zhao
GMGiovanni de Manzoni
Giovanni de Manzoni

28 November 2018 in Diseases of the Esophagus
Verified
Journal Article
Closed access
PDF file
JWJ Weindelmayer
J Weindelmayer
GVG Verlato
G Verlato
LAL Alberti
L Alberti
RPR Poli
R Poli
SPS Priolo
S Priolo
GMG de Manzoni
G de Manzoni
Application of enhanced recovery protocols (ERP) in esophageal surgery seems to lead an advantage in terms of length of hospital staying and outcomes, but only few data exist on its cost effectiveness. Previous literature analyzed pre- and post-ERP groups, finding a cost reduction with the introduction of the pathway. We aimed to study the influence on costs of accumulating experience and compliance in an ERP group. Seventy-one patients have been treated at our institution from January 2014 to June 2017 with our ERP for Ivor–Lewis esophagectomy. Direct costs were divided into subcategories and were analyzed as a function of calendar year and compliance. Factor affecting costs were searched. Univariable analysis highlighted a significant reduction in costs over time. Increase in compliance led to a progressive cost reduction for each ERP item completed (€14 852–€11 045). While age was not found to significantly influence the cost (p = 0.341), complications seemed to nullify the effect of experience: the median was €11 507 in uncomplicated patients, and increased to €13 791 in Clavien–Dindo 3–4 (CD3–4) patients. Compliance and CD3–4 remained significant also in multivariable analysis, accomplished by quantile regression, while year of surgery lost its significance. Our results evidence how accumulating experience in ERP led to a cost reduction over time, which was mainly mediated by an increase in compliance. Indeed, compliance was the main factor in reducing ERP cost while CD3–4 complications were the most important factor in cost increasing, nullifying the benefit of compliance.

31 January 2024 in British Journal of Surgery
Verified
Journal Article
Closed access
PDF file
CPCarlo Alberto De Pasqual
Carlo Alberto De Pasqual
JWJacopo Weindelmayer
Jacopo Weindelmayer
MGMaria C Gervasi
Maria C Gervasi
LTLorena Torroni
Lorena Torroni
MPMichele Pavarana
Michele Pavarana
SGSimone Giacopuzzi
Simone Giacopuzzi
Guidelines on the treatment of oesophageal squamous cell carcinoma (SCC) recommend neoadjuvant chemoradiotherapy plus surgery or definitive chemoradiotherapy. The aim of this study was to evaluate the outcome of patients with a cCR after chemoradiotherapy who underwent active surveillance. Patients with oesophageal SCC who were treated with chemoradiotherapy between January 2016 and June 2022 were identified from an institutional database. Survival and recurrence of patients with a cCR who underwent active surveillance were compared with those of patients who underwent planned surgery. Survival was calculated according to the Kaplan–Meier method and compared between groups using the log rank test. The 37 patients who underwent active surveillance were older and tumours were more often located in the middle/upper-third of the oesophagus than in the surgery group of 57 patients. Median follow-up was 28.1 (i.q.r. 17.2–47.1) months for the active surveillance group and 20 (12.9–39.1) months for the surgery group. Overall survival was comparable between the two groups, with 3-year survival rates of 50 (95% c.i. 31 to 67) and 59 (40 to 73)% for the active surveillance and surgery groups respectively (P = 0.55). Three-year progression-free survival for patients who underwent active surveillance was better than in the surgery group: 70 (43 to 85) versus 58 (40 to 72)% (P = 0.02). Overall and progression-free survival was comparable between patients in the active surveillance group and 23 patients in the surgery group who had a pCR (ypT0 N0). The overall recurrence rate was comparable between the groups: 7 of 37 (19.4%) in active surveillance group versus 16 of 49 (32.6%) in surgery group (P = 0.26). Locoregional recurrence was noted more often in the active surveillance group and systemic recurrence in the surgery group. Active surveillance is feasible and safe for patients with oesophageal SCC who have a cCR after chemoradiotherapy.

24 October 2022 in Updates in Surgery
Verified
Journal Article
Open access
PDF file
VMValentina Mengardo
Valentina Mengardo
JWJacopo Weindelmayer
Jacopo Weindelmayer
AVAlessandro Veltri
Alessandro Veltri
SGSimone Giacopuzzi
Simone Giacopuzzi
LTLorena Torroni
Lorena Torroni
GMGiovanni de Manzoni
Giovanni de Manzoni
Evidence against the use of prophylactic drain after gastrectomy are increasing and ERAS guidelines suggest the benefit of drain avoidance. Nevertheless, it is unclear whether this practice is still widespread. We conducted a survey among Italian surgeons through the Italian Gastric Cancer Research Group and the Polispecialistic Society of Young Surgeons, aiming to understand the current use of prophylactic drain. A 28-item questionnaire-based survey was developed to analyze the current practice and the individual opinion about the use of prophylactic drain after gastrectomy. Groups based on age, experience and unit volume were separately analyzed. Response of 104 surgeons from 73 surgical units were collected. A standardized ERAS protocol for gastrectomy was applied by 42% of the respondents. Most of the surgeons, regardless of age, experience, or unit volume, declared to routinely place one or more drain after gastrectomy. Only 2 (1.9%) and 7 surgeons (6.7%) belonging to high volume units, do not routinely place drains after total and subtotal gastrectomy, respectively. More than 60% of the participants remove the drain on postoperative day 4–6 after performing an assessment of the anastomosis integrity. Interestingly, less than half of the surgeons believe that drain is the main tool for leak management, and this percentage further drops among younger surgeons. On the other hand, drain’s role seems to be more defined for duodenal stump leak treatment, with almost 50% of the surgeons recognizing its importance. Routine use of prophylactic drain after gastrectomy is still a widespread practice even if younger surgeons are more persuaded that it could not be advantageous.

27 November 2020 in Updates in Surgery
Verified
Journal Article
Open access
PDF file
SGSimone Giacopuzzi
Simone Giacopuzzi
JWJacopo Weindelmayer
Jacopo Weindelmayer
GMGiovanni de Manzoni
Giovanni de Manzoni
Due to the difficulties in the intra-thoracic esophagogastric anastomosis creation, totally minimally invasive Ivor Lewis esophagectomy (MIE) did not encountered a large diffusion, preferring hybrid techniques or cervical anastomosis. Robot-assisted minimally invasive esophagectomy (RAMIE) has gained popularity due to an easy reproducibility of the open anastomotic technique. In this feasibility study, we described the RAMIE technique introduced in our Center, providing innovative details for a mechanical end-to-end anastomosis. With patient in prone position, esophagectomy is conducted through the meso-esophagus plan. Robotic hand-sewn purse-string is realized above Azygos vein. A 4-cm thoracotomy in the fifth intercostal space is performed by enlarging the trocar incision. The tubulization is performed to create an access pouch for the introduction of the circular stapler. After the creation of the end-to-end anastomosis, the access pouch is resected and a robotic over-sewn is realized. From January 2020 until July 2020, ten patients were enrolled. No restriction in term of age, BMI, ASA grade or previous surgery were applied. Median operative time was 700 min. R0 resection was achieved in all cases with a good lymph node harvesting. No anastomotic leak or stricture were observed. One chyle leak was treated conservatively. Median length of stay was 8 days and 90 days mortality was 0%. This study evidenced how robotic surgery allowed us to perform the same anastomosis of our open technique with good oncological results and morbidity and length of stay comparable with our previous results. Of note, longer operative time has been recorded. Further studies after the completion of the learning curve are necessary to address more definite conclusions.